Natera: A global leader in cfDNA testing | Icebreaker

Sign up or Log in

Teams

System

Natera: A global leader in cfDNA testing | Icebreaker

Natera: A global leader in cfDNA testing

Natera: A global leader in cfDNA testing

Dedicated to oncology, women’s health, and organ health. Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care.

Contact info

Link

natera.com

Members

•

neuroscience PhD, onchain chaplain for /spirituality, vibe imagineer for /christin, co-host of /bcbhshow for the farcaster middle class. seemore.tv/christin

Worked directly with 1 person

•

Sr Product Manager at GRAIL

•

Over the past two decades in biotech, including 17 years in oncology diagnostics, I’ve led high-performing teams through the launch and scale of technologies that are shaping precision oncology. A career built on firsts has brought some of the most rewarding moments: when a provider orders a test for the first time, and when a result changes patient’s care. That’s where the impact of our work comes to life. From first-to-market innovations in tumor profiling to pharmacogenomics and MRD, I’ve led multistate teams through clinical adoption and operational complexity to repeatedly outperform high-stakes commercial goals. I believe in building strong, aligned teams, and coaching people to win through strengths-based leadership, clear expectations, and shared accountability. Developing people is one of the most fulfilling parts of my role. I’ve coached top performers, helped individual contributors grow into people leaders, and guided new managers to lead with confidence. My teams consistently deliver results, earning President’s Club honors and driving promotion pipelines year after year. Outside of sales leadership, I stay grounded in work that expands access, equity, and representation in healthcare. I chaired the Women of Natera Leadership Team, where we partnered with executives to launch tailored professional development programs, bring new benefits to employees, and strengthen the future pipeline of women leaders. As a founding board member of Breast Care for Washington, I helped raise $1.5M and led digital strategy to launch a breast cancer screening center that reached 1,500+ underserved women in its first year. I also supported the rareREACH launch with Rare Genomics Institute, helping bring long-awaited diagnoses to families with rare diseases. I hold a BA in Economics from Bucknell University, an MBA from the University of Maryland, and certifications in Patient Engagement and Healthcare Marketing.

•

Product Management & Commercial Leader

•

Bernhard Zimmermann

•

Developing new technologies and diagnostic applications for Natera (Oncology, women’s health and transplant monitoring. Focusing on cfDNA testing. Lead inception, development, validation and launch of: - Signatera - Panorama - Prospera Main inventor of massively multiplex PCR targeted sequencing, from inception to launch. Over 100 granted patents and 50 peer reviewed publications.

•

TO OBTAIN AN EXECUTIVE POSITION OF BUSINESS DEVELOPMENT IN A DYNAMIC WORK ENVIRONMENT, WHERE EXPERIENCE AND PROFESSIONALISM ARE VALUED AND REQUIRED AS MEANS FOR ATTAINING COMPANY SUCCESS. Areas of Expertise: Developing New Business Relationship, Referral Partnership, Account Management, Sales and Marketing Programs, Territory and Sales Management Strategy, Consistent Top Producer, Diagnostics, Genetic Testing, Contract Negotiations, Practice Implementation.

Michelle Bloom, PhD, ISMPP CMPP

•

Manager, Scientific Affairs at Natera

•

Versatile and efficient administrative professional with a proven ability to provide executive-level support and drive organizational excellence. Adept at managing complex schedules, coordinating high-profile meetings, and ensuring seamless operations for executive teams. Skilled in event planning, expense management, and cross-functional collaboration.

Shephalie Lahri Chitkara

•

My drive is rooted in making personal connected health accessible by simplifying our complex bodies into practical insights. Informed individuals take ownership of their health. Despite delivering dependable, clinically accurate information (clinical validity) to our doctors and patients, the challenge lies in conveying its significance right now (clinical utility). That is why I’m committed to making personal digital and diagnostic data friendly and actionable. This is a key theme through my 13+ years in healthcare. At Natera, I launched a $76M transplantation business unit and expanded markets for mature brands, including the now number one non-invasive prenatal test. To do so, I led cross-functional teams to educate patients, doctors, health plans and employers, while shaping product roadmaps driven by customer feedback. Prior to Natera, I was selected to start PwC’s Healthcare Innovation Incubator to create and scale service offerings for Fortune 500 clients to stay relevant and uniquely engage with their customers on the healthcare trends of today. Specialties: go-to-market, product marketing, marketing communications, branding, launch leadership, market research, competitive analysis, brand management, joint business relationships, due diligence, commercialization, market access, partnerships, marketing strategy, go-to-market strategy, customer insights, strategic planning, team leadership, digital health, diagnostics

…